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Abstract  
i. Research question: How can we improve implementation of NHLBI Sickle Cell disease 
guidelines in Emergency Department(ED) protocols? 
ii. Importance: Many EDs are not using the evidence-based guidelines established by NHLBI for 
the care of patients with SCD. Patients often suffer from pain treatment delay, under-treatment 
of their pain, and report high levels of dissatisfaction with care. When the NHLBI guidelines are 
not incorporated seamlessly into treatment protocols, the quality of care for patients with SCD is 
not as high as it should be, and may be poor.  
iii. Specific aim: I interviewed Emergency Department stakeholders involved in the ED’s care of 
patients with SCD to determine barriers to and opportunities for potential care approaches that 
can improve implementation of NHLBI SCD guidelines into the ED’s SCD management 
practices. 
 iv. Methods: I digitally recorded interviews with ED leaders at UNC’s Hospital main ED using a 
semi-structured interview questionnaire, in order to uncover the current status of sickle-cell 
disease care in the ED, the current barriers to improving care, and explore potential solutions to 
improving implementation of guidelines. 
v. Results: Results revealed the need for ongoing education of ED medical staff on sickle-cell 
disease management and the condition in order to debunk stigma and biases and improve 
implementation of the current individualized pain plans and PCA pump initiatives. Additionally, 
the study uncovered the need for a systematic approach to implementing the 2014 NHLBI SCD 
guidelines in an effort to improve consistency of care. Lastly the study exposed the demand for 
better communication between ED provider and SCD specialist. The results most importantly 
offered fundamental solutions to addressing each of these problems. 
vi. Discussion and conclusions: Given the study results, four fundamental policy 
recommendations were crafted to address the three major gaps in SCD management 
highlighted by the study results. These includes providing more education on a SCD and 
treatment guidelines to ED medical staff, making individualized plan plans the standard of care, 
using EPIC (EMR) to create SCD-based order sets, and improving ED provider and SCD 
specialist’s communications. 
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Introduction 
 Sickle cell disease (SCD) is a genetically inherited chronic illness that has been affecting 
African people for at least 5000 years (Winter). In 1910, the molecular basis for the disease was 
discovered with the identification of sickled-shaped RBCs beneath the lens of a microscope by 
U.S. Cardiologist Dr. James B. Herrick and his resident Dr. Walter Clement Noel (Winter). Later 
on, SCD was found to be a condition in which an individual’s RBCs became sickled as a result 
of physiologic stressors such as dehydration, exertion, cold weather and more. Today, the 
disease affects millions of people worldwide (Sickle Cell Disease, 2016). In the U.S. the exact 
number of individuals living with SCD is unknown, however it is estimated that close to 100,000 
people are affected by the illness  (Sickle Cell Disease, 2016). The condition mainly affects 
people of African, Mediterranean, and Asian Descent, though in the US, it predominantly affects 
African Americans  (Sickle Cell Disease, 2016) (National Heart, Lung, and Blood institute: Who 
Is at Risk for Sickle Cell Disease?, 2015). The disease is known for its ability to affect nearly all 
major organ systems, including the lungs, kidneys, eyes and more. The common complications 
of the disease include vaso-occlusive crisis (VOC), splenic sequestration, stroke, acute chest 
syndrome (ACS) and infection just to name a few. However, the most commonly occurring SCD 
complication is the vaso-occlusive crisis or sickle cell pain crisis. Among adults and children with 
SCD, the VOC is the most common reason for emergency department (ED) visits and 
hospitalization (Sickle Cell Disease: Complications and Treatment, 2015).  
The VOC is thought to result from abnormally shaped RBC occluding blood vessels, 
which leads to downstream effects such as tissue ischemic and/or organ damage, resulting in 
extreme pain. The extreme pain can commonly present in the patient’s back, arms, legs, pelvis, 
abdomen and chest. But in actuality the pain can present anywhere.  Patients experiencing a 
VOC typically describe their pain as extreme and persistent throbbing, pounding, or banging in 
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character. Classically VOC can last from three to nine days, but may be longer or shorter in 
duration. VOC can be caused by certain triggers such as physiologic stress factors that increase 
the patient percentage of sickled red blood cells, as mentioned above. However, VOC can often 
have no precipitating causes that can be identified. VOC can be classified as complicated and 
uncomplicated. Complicated VOC generally indicates the VOC is happening concurrently with 
another medical complication (e,g, ACS, infection, MI, etc.). Uncomplicated VOC denotes that 
the VOC is occurring in the absence of other medical complications or illnesses. 
  The VOC condition cannot be clinically diagnosed using any type of lab test, clinical 
imaging device, or physical exam technique. From a patient perspective, the VOC condition is 
easy to treat, given that the core tenets for treating an uncomplicated VOC are IV fluids to 
correct any dehydration, parenteral opioids to treat pain, and time to let the pain pass on its 
own. From a medical perspective, the condition can be difficult to treat given clinicians’ and 
medical teams’ reluctance to give the patient adequate analgesia for tolerable pain control. The 
reluctance to treat and manage the patient’s pain is the root of the problem. This resistance 
stems from clinician hyper-concern with drug addiction in this patient population. This 
heightened concern fostered the birth of a stigma, among the ED medical teams, that many 
patients with SCD seeking care in the ED for VOC pain are drug seekers. This stigma had many 
negative effects on the quality of care delivered to patients with SCD. In an attempt to improve 
quality of care for patients with SCD, the National Heart, Lung, and Blood Institute (NHLBI) 
released evidence-based management guidelines in 2014 for the treatment of all aspects of this 
disease and its complications, and most importantly the VOC. However, according to the 
literature, these guidelines are not being used by the ED medical teams. As a result of this 
commonly held stigma and lack of knowledge about ED management of this condition, 
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 the current ED VOC quality of care is deemed unacceptable by most SCD stakeholders.  
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Background and Significance 
 In order to illustrate the complexities of this quality of care shortcoming, I will review the 
background and context on the 2014 NHLBI SCD management guidelines, the clinician’s 
traditional perspective on pain management, and insight into current VOC quality of care 
shortcomings. According to the 2014 NHLBI SCD management guidelines when a patient with a 
VOC arrives at the ED and is triaged, he or she should be given an emergency severity index 
(ESI) score of two of five, which signifies that the patient medical condition is high priority 
(Buchanan, Yawn, Afenyi-Annan, & Al, 2014). Thereafter the patient should receive rapid 
initiation of parenteral opioids within either thirty minutes of triage or sixty minutes of ED 
registration. With respect to management, guidelines recommend that clinicians’ analgesic 
approach be based on “pain assessment, associated symptoms, outpatient analgesic use, 
patient knowledge of effective agents and doses, and past experience with side effects” 
(Buchanan, Yawn, Afenyi-Annan, & Al, 2014, p. 34). After initiation of opioid therapy, the 
physician should continue to re-administer initial analgesia doses or consider increasing initial 
doses by upwards of twenty-five percent every fifteen to thirty minutes until the pain is reported 
to be controlled (Buchanan, Yawn, Afenyi-Annan, & Al, 2014). If available, guidelines advise 
clinicians always to use a patient’s individualized prescribing and monitoring protocol (crafted by 
the patient and his or her SCD specialist) in order to provide the most rapid, effective, and safe 
pain management therapy (Buchanan, Yawn, Afenyi-Annan, & Al, 2014). This is not an all-
inclusive summary of the VOC treatment guidelines; however these recommendations highlight 
how aggressively VOC pain should be managed, and how important patient input and feedback 
should be to the VOC management process. 
 Historically, it has been established that the majority of ED physicians and nurses hold 
beliefs that patients with SCD have a higher prevalence of drug addiction than do all other ED 
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patients with pain (Tanabe, Hafner, Martinovich, & Artz, 2012) (Shapiro, Benjamin, Payne, & 
Heidrich, 1997). However according to the literature, the estimated prevalence of opioid 
addiction in the sickle cell population is equivalent to that of the general population(less than 
10%), not supporting beliefs about higher addiction rates among SCD patients (Solomon, 2008) 
(Shapiro, Benjamin, Payne, & Heidrich, 1997). Given that many ED providers apply the drug-
seeking stigma to patients with SCD, patient care for those with VOC may be harmed. First, this 
stigma fosters a degree of discomfort with respect to treating the SCD patient population. This 
lack of comfort then breeds an element of mistrust in the clinician and patient relationship prior 
to seeing the patient. Clinicians often become overly concerned about drug seeking behavior. A 
study of physicians’ attitudes and practices in SCD pain management has shown that clinicians’ 
concerns about patient addiction in those with SCD have contributed to under-treatment of 
patient pain (Labbé, Herbert, & Haynes, 2005). Clinicians harboring this concern about patient 
addiction may believe that undertreating the patient’s pain can prevent opioid addiction, 
dependency, and/or that they can treat opioid addiction by not enabling the supposed drug-
seekers. This discomfort then becomes exacerbated if the provider has knowledge gaps about 
the disease process or discomfort with general pain management. 
 From a clinician’s perspective the 2014 NHLBI guidelines for management of the SCD 
VOC may seem contrary to the traditional practices of emergency medicine with respect to 
controlling pain. These guidelines recommend that providers in the acute setting immediately 
trust and rely on patient input for analgesia type and dosing, given there is no other clinical test 
to diagnose and assess for condition status and response to treatment, and only the patient can 
indicate the presence of a VOC. Given the scenario of a patient coming in with a complaint of 
pain and no abnormal finding on testing, and the patient is asking for a specific dose and type of 
medication, orthodox training would lead  the clinician to  be apprehensive about medicating the 
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patient…in training, clinicians are warned about drug seeking behavior. When, on the other 
hand, a patient presents in VOC, a condition that has been well characterized over the past 100 
years as having a pathophysiologic basis for causing pain, and the patient is getting the level of 
treatment comparable to that of a drug seeker, the rational for this dehumanizing quality of care 
is inexcusable and unjustifiable even within the context of this traditional clinician perspective on 
treating pain.   
  The 2014 NHLBI guidelines for VOC management are not being implemented to the 
degree they should, and quality of patient care continues to suffer as a result. According to the 
literature, the sickle cell patient population is reporting high levels of dissatisfaction with care, 
delays in treatment of pain, and under-treatment of pain both in the ED and in-patient setting 
(Mathias & McCavit, 2015)1 (Glassberg, et al., 2013). Many EDs across the U.S. have 
measured their average time to analgesia administration for patient with SCD to be in excess of 
80 minutes from triage departure  (Mathias & McCavit, 2015) (Lazio, et al., 2010). This 
treatment initiation is nearly an hour beyond NHLBI guideline recommendations. In a 2010 study 
comparing ED analgesic pain management practices of patient with SCD vs. renal colic (kidney 
stone), the study found  that “ED patients with SCD experienced longer delays in the 
administration of the initial analgesic compared with renal colic patients, despite higher arrival 
pain scores and triage acuity levels” (Lazio, et al., 2010, p. 199). On average patient with SCD 
were found to wait upwards of 30 minutes longer to receive initial analgesia in comparison to 
patients with renal colic (Lazio, et al., 2010). Thus care and timing to analgesia does have the 
potential to improve for patients with SCD, and the literature supports the fear that this care is 
being delayed.  
                                                             
1
 Primary source within the cited secondary source could not be located. 
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 ED VOC quality of care is suffering for the following main reasons: guidelines are not 
being followed; the drug-seeking stigmatization is harming the physician–patient relationship, 
leading to under-treatment of pain; and analgesia care is delayed in the treatment of these 
patients. With these shortcomings in mind and for the purposes of improving quality of care for 
patients with SCD, the objective of this study is to uncover solutions to improving 
implementation of NHLBI SCD guidelines in the ED. This study involves the recruitment of ED 
leaders (Physicians, Nurses, Trainees and Pharmacists) interviewed with a semi-structure 
interview protocol (see Appendix 2).   
Methods 
Ethical consideration 
This study was approved by the Institutional Review Board at UNC Chapel Hill (IRB No. 
16-1054). Participants, all Emergency Department stakeholders at UNC Hospitals, were free to 
withdraw from the study at any time. The consent process required stakeholder consent to be 
interviewed either in person or over the phone. The interviews were audio recorded with 
permission from the participant, beginning with a recording of consent, and respondents were 
asked for permission to name them and to use direct quotes from their interviews.  I promised 
anonymity to those who did not wish to be named. Each participant had to be consented for 
publication of their name, job title, and direct quotes. The consent process was audio recorded 
for all participants. Subsequently, audio and written consent were obtained from each 
participant.  
Participant Recruitment 
I recruited, consented, and interviewed all study participants.  I conducted interviews in 
June 2016. I used the UNC ED “people” directory to search for nurse, pharmacy, and physician 
leaders, in addition to snow-ball sampling. I recruited interviewers via email messages and I 
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attempted to schedule an interview with those who responded. I recruited 13 potential 
respondents and 7 agreed to participate. They are listed in Appendix 3.   
Data Collection and Analysis  
I transcribed all interviews and coded them with a particular focus on identifying barriers 
and recommend policy based-solutions for improving implementation of NHLBI SCD 
management guidelines in UNC Hospital’s ED.  
Results 
In order to uncover the current status of sickle-cell disease care in the ED, the current 
barriers to improving care, and to explore potential solutions to improving implementation of 
guidelines I examined the interviews according to 10 major topics of sickle-cell care in the ED. 
 
SCD Management Education in the ED 
Overall, when the ED leaders were asked how often do ED providers and trainees 
discuss ED management of patients with sickle cell disease 4 out of my 7 stakeholders 
responded that the discussion occurred most commonly on a patient to patient basis, and 
usually occurred during or immediately after care is given. Additionally most ED leaders a 
different 4 of the 7 explained that most ED providers (especially  nurses and trainees) received 
the majority of their SCD population level education via certification exams, annual training 
exams, ED conferences, and/or resident training conferences. However with respect to 
continuing education for SCD management by either medical staff or trainees, all but one of my 
respondents said they knew of no special training or seminar requirements on sickle-cell 
disease management. 
 
SCD Quality of Care Efforts Currently 
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The overwhelming majority of ED leaders (6/7 stakeholders) felt that we could do better with 
respect to improving management of sickle-cell disease patients: 
“To be honest, I think there are a number of us that think that we could do a better job 
than our status quo” (Hatfield, 2016) 
In particular, when one of the ED leaders was asked how does the ED as a whole think about 
improving SCD management as a quality of care problem? They responded: 
“I would say probably not aggressively enough” (Leader 1, 2016) 
A minority (2/7 stakeholders) said the current PCA (Patient-Controlled Analgesia) initiatives and 
individualized pain plans created a couple years ago were good quality improvement initiatives, 
but currently we need to better abide by them. 
 
Are Guidelines Enough to Improve Implementation? 
I asked all the ED leaders if guideline accessibility was a problem. All of the stakeholders 
responded that the guidelines were easily accessible. However there are other barriers to using 
them. The majority of ED leaders (4/7 Stakeholders) responded that guidelines were not 
enough, and that we needed more in order to improve their implementation. UNC Hospital’s ED 
Associate Professor Dr. Kevin Biese represented other stakeholders well when he was asked 
whether guidelines were enough to improve implementation: 
….there is a long distance to travel between writing guidelines and having them 
implemented. It’s not having the availability of the guidelines that makes them easier to 
implement. It’s creating systems that support implementation of the guidelines. So I think 
that they’re accessible, but I don’t think that’s adequate enough to get the results that we 
need, which is their application. (Biese, 2016) 
 
Improving guideline implementation with EMR system 
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EPIC is UNC Health Care’s electronic medical record. When the stakeholders were 
asked how EPIC could improve the usefulness of guidelines, the overwhelming majority of ED 
leaders (6/7 ED leaders) agreed that EPIC would be a useful solution to this problem. 
Specifically, the majority of ED leaders (4/7 Stakeholders) responded that EPIC could be used 
to standardize the use of individualized pain plans for patients with SCD. Four out of seven ED 
Leaders also said that EPIC could be used to create customized treatment bundles or work 
order set protocols for patients who present to the ED with SCD. One of ED leader explained 
the potential of this technology particularly well: 
“[In] EPIC you can...create what we call...an order set….and what that is, is a 
comprehensive… algorithm built within EPIC and you can go in [and] click SCD pain 
crisis and it will automatically populate based on the guidelines all the labs you need to 
order, fluids, medications. It will direct you to specific things to think about ...I think with a 
stepwise algorithmic approach like that it ties in very nicely to the guidelines but makes it 
applicable with our day-to-day computer system. …On average …it takes us about 6-8 
months for us to develop a treatment bundle. (Hatfield, 2016) 
The ED leaders added that we could use EPIC to make the current individualized pain plans 
time-based and threshold based via the use of time triggers within SCD based order sets, if we 
did create an ED SCD order set.  
 
Current things that work really well with ED SCD management 
When the ED leaders were asked from their vantage point what things worked really well 
in the ED management of patients with sickle cell disease, the majority did not converge on one 
particular thing. Two of the seven ED leaders agreed that triage worked really well for patients 
with sickle cell disease. Specifically, they felt that sickle-cell disease patients were appropriately 
triaged with a higher ESI score, ranging from 3 to 1, if they arrived at the ED with a VOC. A 
 11 
 
UNC MD felt the PCA pump utilization works really well for patients with SCD who present in 
pain. Another ED faculty member responded that we could improve upon this PCA initiative by 
further educating our staff and trainees on use of this technology, in order to further improve 
utilization (Leader 2, 2016). Nurse Manager Jeff Phillips responded that we could improve on 
our individualized pain plans initiatives by taking the next step:  
…working in EPIC and seeing updated care plans for each particular 
patient…..[because] they are not implemented very well now, [specifically] they are more 
for the patients who are complicated. (Phillips, 2016 ) 
 
Greatest Barrier to Improving Sickle-Cell Care in the ED 
I asked the ED leaders about the biggest barriers they saw to improving SCD care and 3 
of 7 responded that lack of consistency in care was the greatest barrier. One faculty member 
summarized the problem very well: 
So many different doctors and residents do it [SCD pain management] different ways. 
So you can come in one day and get one kind of care and pain medicine and the next 
day…get a different kind. So I think not having it standardized now is not as good for the 
patient as making it [SCD pain management] standardized. (Leader 1, 2016) 
According to the Dr. Leah Hatfield: 
Organization is one of our biggest limitations right now. And second …is education 
having everyone, physicians, residences, nurses …all of our therapists and …all of our 
pharmacists understand sickle-cell really well. I feel like we have certain sort of 
champions that do… and we have others where I think it is sort of misunderstood and in 
particular understanding pain in sickle cell a lot better. So I think mandatory education on 
pain management for sickle cell patients would be a big added bonus. I see a lot of fear 
in using high doses of pain medication or frequent administration and I will hear the term 
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that sometimes we are going to get them addicted, we are going to create problems for 
them….And the reality is that we need to treat their pain. (Hatfield, 2016) 
When Dr. Hatfield was asked how we could dismantle this barrier, she responded: 
I think just communication and education. I think it’s something easily overcome and 
…most of the time when I encounter these things with various disease states….it’s just 
an education deficit and then once there is greater education or communication on 
things they resolve themselves very quickly. (Hatfield, 2016) 
According to another faculty member, 
Patient arrival to medication administration is a big issue….. [And that a potential 
solution to that barrier was] managing patients by acuity in making sure we have enough 
staff to meet those acuities. (Leader 2, 2016) 
Dr. Kevin Biese said 
I think that there is a few of them…So one of the barriers to really making the 
system better for patients with repeated episodes of pain is to overcome biases against 
treating the pain while at the same time being aware that we do it in a way that is safe. 
So it’s hard to navigate through that. I think that there’s also cultural and sort of cultural 
biases that affect the way that people perceive people from different cultures that have 
pain. And I think that….it’s reality….most health care providers are white and patients 
with sickle cell disease are of African-American heritage and that there can be divides 
there and there can be judgments there with patients that is not warranted, and 
sometimes makes it even harder for them to get the care that they need. And I think that 
all of our providers do the best to be providers and none of them are overtly biased 
against anyone, but biases and cultural values influence all the decisions we make…one 
of the barriers is unawareness of our own culture biases and the solution to that is a 
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greater awareness of those, and being proactive to sort of overcome biases that we may 
have to make sure that we do the best we can to take care of our patients. (Biese, 2016) 
 
Preparedness of the ED to Care for Patients with Sickle Cell Disease 
When the ED leaders were asked how well prepared the ED was to care for patients 
with sickle cell disease, given the barriers they currently face, the majority of ED leaders (6/7 
Stakeholders) responded that the ED is well prepared to care for patients with sickle cell 
disease. Additionally the majority of the stakeholders (4/7 ED leaders) responded that ED care 
for these patients could be better. 
 
Individualized Pain Plans and Making them the Standard of Care 
When the ED leaders were asked about their views on improving the use of 
individualized pain management plans, the majority of clinicians had many specific suggestions. 
Two of the seven ED leaders responded that the individualized pain plans should be patient 
centered. Typically, individualized pain plans usually specify type of medications, dosing, and 
frequency at which medications should be administered. However, leaders want to make these 
individualized pain plans more patient-centered with respect to applying certain things that are 
more applicable to each person, according to Nurse Manager Jeff Phillips. For example, Dr. 
Hatfield said that if patients for whatever reason don’t want PCA therapy, while PCA is a 
standard of care, then ED care should be flexible enough to accommodate, and that those 
desires should be documented within the individualized pain plan. Another two of the seven ED 
leader agreed that the individualized pain plans should have a centralized location within EPIC, 
and that location should be the FYI tab, which is already the location of the majority of 
individualized pain plans. However, currently there is no standardized or agreed upon place 
where these individualized pain plans exist in EPIC, according to Dr. Hatfield. Of the seven ED 
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leaders, three responded that the individualized pain plans should be crafted by the patients and 
their own sickle-cell disease providers, because these providers have relationships with these 
patients and could create truly patient-centered plans. 
 When I asked ED leaders how we could make the individualized pain plans the standard 
of care the ED leaders (3/7 Stakeholders) agreed that the ED and EPIC committee would have 
to agree on how they would incorporate individualized pain plans in EPIC, then subsequently 
the medical staff would have to be educated on the new individualized treatment. A few of the 
ED leaders (2/7 Stakeholders), said that currently some ED providers are hesitant in using the 
individualized pain plan protocols that are in place now. In response to this problem many ED 
leaders had solutions.  Dr.  Hatfield said they felt that having a 
…task force of folks that can really drive education and understanding and sort of 
compliance, for lack of a better term, within the Department… and then having that 
[individualized pain plan and SCD order set] bundle that goes through approval through 
the Department and then approval from a hospital based perspective that says that this 
is now…. the evidence based gold standard  way that we are going to manage these 
patients … And I think that one it’s a multi-piece thing but having a group of 
champions…that helps to get everyone on board, and having the order set that allows 
you to get on board easily and then ….[the] last step is making sure that you develop a 
….patient-centered model from the very beginning that lends itself to…. more flexibility 
and understanding of these patients as individuals. (Hatfield, 2016) 
Dr.  Biese said 
We would advocate strongly at a leadership level in the Department that those plans are 
followed. If there was a problem with the plan rather than refusing to give to the patient 
that time, the correct channel would be set up for our Department to communicate back 
to the primary care provider and say, “Wait, we’re not comfortable with this aspect of the 
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plan. Let’s talk together about making a new plan that we’re comfortable with”….. If there 
were any reasons or concerns to not utilize them then we would expect to be notified, 
and we would expect them to email [ED Attending Leadership] … and email the person 
that wrote the care plan, and say that I’m concerned because of this and that. You 
cannot follow it and then not tell them that you’re not following. (Biese, 2016) 
 
Improving ED Provider Communication Referral with Sickle Cell Specialist 
The ED leaders were asked how they could improve communication with the patient’s 
SCD providers. The majority of ED leaders (4/7 Stakeholders) responded that we could improve 
our notification to the Hematology Department in order to follow up with patients that are 
discharge from the ED, if the patient is seen at UNC Hematology Department. Specifically, UNC 
Emergency Medical Service’s Director Christian Lawson responded 
If the patient isn’t going to be admitted and going to be discharged we have worked with 
a few other clinics, the DVT clinic and a fib clinic, to actually get follow-up appointments, 
where our health unit coordinators have actually scheduled follow-up appointments for 
the patient and their clinic so when they’re discharged the next day or day following, they 
follow right up [and] they get appointment when they leave the ED, that’s continuity of 
care. And I would really like to see how we could go around that…I would be more than 
happy to talk to the clinic leadership about having a conversation about if this is even 
possible or is this feasible. (Lawson, 2016) 
In response to the SCD patients who often present to the ED and who have barriers to 
following up in the sickle-cell disease clinic for chronic care, Dr. Biese said for patient who show 
up very frequently in the ED, EPIC should, if not already programmed to do so, automatically 
notify that patient’s sickle-cell provider within our health care system, requesting that they 
proactively reach out to the patient in some capacity, as a solution. 
 16 
 
 
ED Provider Comfort Level with Managing SCD 
I asked ED leaders to judge the comfort level of their health care providers at UNC ED.  
Six out of seven responded that overall ED staff are comfortable with caring for patients with 
SCD. One faculty member who wanted to remain anonymous said  
it’s[provider comfort level] probably all over the place; for the people who don’t see a lot 
of sickle-cell they may be a little more uncomfortable, than people who see it more often 
they may be a little more comfortable” (Leader 2, 2016) 
When providers were asked how we could further improve the comfort level of providers 
managing patients with SCD, the majority of ED leaders (5/7 Stakeholders) responded that 
there is a need for more ongoing education about this disease. These same ED leaders (5/7 
Stakeholders) agreed that there is still a drug seeking stigma surrounding the treatment of SCD 
patients. In response, these 5 of 7 stakeholders called for more education to overcome that 
stigma. Dr. Hatfield said 
I would love to see a seminar with…one sickle cell expert clinician coming to speak 
about the disease itself and pain. And what [is] our normal expectation? And what is 
normal management and again guideline driven care? Another thing I [would] really like 
to see is patient involvement, having patients come to talk about what it’s like to live with 
SCD every day or what it like to have a family member’s live with sickle cell every day. 
What’s it like to have a pain crisis, and what’s the difference between when its managed 
well [in the healthcare setting] and not managed well, because I think that is what really 
drives it home to us as providers…. when we hear from the patients... [then] we can 
put… the sciences with the person and I think that is what really pulls it all together. 
(Hatfield, 2016) 
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Discussion 
This study has shown there are many barriers to improving implementation of the NHLBI 
guidelines for managing sickle-cell disease. However the ED leaders who participated in the 
study have demonstrated that there are many potential system-based and educational solutions 
to improving implementation and utilization of the guidelines, in an effort to improve overall 
quality of care for patients with sickle cell disease who present to the ED. 
Current Status of Sickle-Cell Care and Barrier to Improving  
 Over the past couple of years two initiatives have been used to improve the quality of 
care of patients with sickle cell disease who present the ED, the PCA pump and individualized 
pain plan initiatives. Both of these initiatives have not yet been effectively incorporated into the 
ED management process. Both PCA pump initiative and individualized pain plans need to be 
used more consistently. Currently individualized pain plans are used only for the more 
complicated sickle-cell patient.  Other individualized pain plans, although implemented, are not 
consistently used. 
 The overwhelming majority of ED leaders felt that we could do better when it comes to 
quality. The guidelines alone are not enough to improve quality of care; respondents said that 
we need more system-based approaches to improving utilization and implementation of the 
guidelines. At present, the majority of ED leaders agreed that the greatest barrier to improving 
SCD care is the lack of consistency in care management of these patients, including managing 
the timing to analgesia administration.  
 The majority of ED providers are comfortable with managing patients with sickle cell 
disease although a minority of providers is uncomfortable with treating this patient population. 
The drug seeking stigma persists, and ED leaders agreed that there needs to be more 
education to overcome the stigma. Stakeholders said the majority of education is provided on a 
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patient to patient basis and via general education outlets such as certification exams, annual 
training exams, ED conferences and/or training conferences, but not via special, dedicated 
training or seminar requirements on sickle-cell disease management. Many providers felt that 
there is a great need for such specific education, especially on best practices in pain 
management, individualized pain plans, and the PCA pumps.  
ED leaders felt that we are currently well prepared to care for patients with sickle cell 
disease but we can do better by focusing on system-based solutions. 
 
Policy recommendations for improving SCD quality of care and Guideline 
Implementation 
The four main policy recommendations that this study uncovered included providing 
more education on sickle-cell disease and treatment guidelines, making individualized pain 
plans the standard of care, improving ED provider and sickle cell specialist communication, and 
using EPIC (EMR) to create sickle-cell-based order sets or treatment bundles. 
 
Making Individualized Pain Plans the Standard of Care 
 The majority of ED leaders believe that we could use EPIC to make individualized pain 
plans the standard of care for patients with sickle cell disease. ED leaders said this initiative 
would improve consistency of care and further limit room for bias in the treatment of these 
patients. With respect to individualized pain plan specifics, the majority of ED leaders agreed 
that individualized pain plans should be created by the patient with his or her sickle-cell disease 
provider and that the plan should include patient-specific needs, such as clear indications of 
whether the PCA pump is what the patient wants. Stakeholders called for a task force or group 
of sickle-cell champions to educate and help everyone embrace current and future systems of 
care management, including individualized pain plan, in order to breed compliance with 
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guidelines and best standard of care. Stakeholders also insisted that providers need to follow 
individualized pain plan pathways, and that communication channels to the sickle cell disease 
provider remain open and strong. 
 
Using EPIC (EMR) to Create Sickle-Cell-Based Order Sets 
 This study also demonstrated that the majority of ED leaders believe EPIC can be used 
to create customized treatment bundles for patients who present with sickle cell disease in the 
ED. The use of order sets can improve the feasibility of initiating an individualized pain plan, in 
addition to improving consistency of care, according to the ED leaders. The order sets will also 
improve consistency and feasibility of ordering labs, imaging, and will potentially provide an 
innate algorithm for reminding clinicians as to whether the patient needs certain treatments such 
as oxygen, IV fluids, and EKG. ED leaders have also proposed that through the use of a built-in 
EPIC order set for patients with sickle cell disease an individualized pain plans could be made 
time-based via the use of time triggers and reminders. 
 
Improving ED Provider and SCD Specialist Communication 
 The majority of ED leaders agree that we could improve our notification to the 
Hematology Department about patients with sickle cell disease who present for care and are 
discharged directly from the ED. This measure would effectively serve to improve follow-up 
appointments, potentially reduce readmissions, and improve continuity of care for patients with 
sickle cell disease who present to the ED. For patients who experienced barriers to follow up in 
the sickle cell disease clinic, one ED leader suggested that we could use EPIC to automatically 
notify the patient’s SCD provider if the patient is appearing frequently in the ED. This could 
enable hematology providers to reach out early to the patient in an effort to better manage his or 
her disease, despite any other barriers the patient faces. 
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Education on Sickle-Cell Disease and Treatment Guidelines 
 Providers need further education on sickle-cell disease, its management, and the new 
treatment guidelines. The majority of ED leaders agreed that we need more education in order 
to overcome the stigma of drug-seeking. A few ED leaders proposed that sickle-cell expert 
clinicians should potentially come in and speak about the disease itself and the pain, in addition 
to expectations for normal management and guidelines of care. These ED leaders also 
proposed that a SCD patient could even be invited to participate in these annual or semiannual 
SCD seminars to talk about life with SCD, good ED care experiences, and poor ED care 
experiences.  This would connect the science behind the disease to the patient experience and 
show providers in a vivid and immediate way how the ED can foster better patient care 
experiences now and in the future. 
 
Study limitations 
 The major limitation of this study was the small number of stakeholders who agreed to 
be interviewed,  ED leaders are all very busy, and follow-up communication was a barrier to 
recruiting more participants that initially agreed to be interviewed, but could not schedule a time 
to do it. This limitation could be addressed by extending the duration of the recruitment period.  
This study did not include any interviews with patients, and being able to add the patient 
perspective would be a strength. This study did not include any interviews with SCD specialist 
which could have provided more solution and deeper prospective of potential barriers to 
improving care. 
Conclusion 
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With the help of seven ED leader participants, I have identified four fundamental policy 
recommendations to improve SCD care in the ED. The four main policy recommendations are 
providing more education on sickle-cell disease and treatment guidelines to ED medical staff; 
making individualized plan plans the standard of care; using EPIC to create SCD-based order 
sets, and improving ED provider and SCD specialist’s communications. With the implementation 
of these four initiatives, ED management of patients with sickle cell disease can be improved at 
its very foundation. 
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Appendix 1: Systematic Review 
Introduction and background  
 
Approximately 90,000 to 100,000 Americans have Sickle Cell Disease (SCD) (National 
Heart, Lung, and Blood institute: Who Is at Risk for Sickle Cell Disease?, 2015). The 
populations affected by this disease are of African, Mediterranean, and Asian descent (National 
Heart, Lung, and Blood institute: Who Is at Risk for Sickle Cell Disease?, 2015). SCD can affect 
nearly all major organ systems. Some of the common complications of sickle cell anemia 
include recurrent pain episodes, acute chest syndrome, stroke, and infection (Sickle Cell 
Disease: Complications and Treatment, 2015; Sickle Cell Disease: Complications and 
Treatment, 2015). Of the disease’s many complications, the vaso-occlusive pain crisis (VOC) is 
the most frequently occurring one and the common reason patients with SCD seek care in the 
emergency department (ED) (Sickle Cell Disease: Complications and Treatment, 2015) 
(Tanabe, Hafner, Martinovich, & Artz, 2012). Patients and families receiving treatment for VOC 
in the emergency department report high levels of patient dissatisfaction, delays in treatment, 
and under-treatment of the pain (Mathias & McCavit, 2015)2 (Glassberg, et al., 2013).  
 In 2014, the National Heart, Lung, and Blood Institute (NHLBI) issued evidence-based 
care guidelines for managing patients with SCD. But, despite the presence of several well-
defined guidelines, the EDs’ management of the VOC is still inadequate (Krishnamurti, Smith-
Packard, & Gupta, 2014). Since the 1990s, it has been well documented throughout the 
literature that arguably the two major barriers to implementing the use of guidelines are 
                                                             
2
 Primary source within the cited secondary source could not be accessed. 
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incomplete education of providers about guidelines, and the routine fear that adult SCD patients 
are drug-seekers.  Understanding the power of these implementation barriers requires context.   
Historically, it had been established that the majority of ED physicians hold beliefs that 
patients with SCD have a higher prevalence of drug addiction than does the general population 
(Shapiro, Benjamin, Payne, & Heidrich, 1997). According to a nationwide survey, fifty-three 
percent of ED physicians believed that more than one-in-five patients with SCD are addicted to 
pain medication (Shapiro, Benjamin, Payne, & Heidrich, 1997).  This is a prevalence estimate 
on physicians’ parts that far exceeds that of the general population. The estimate of the actual 
prevalence of opioid addiction in the sickle cell population is equivalent to that of the general 
population, at less than 10% (Shapiro, Benjamin, Payne, & Heidrich, 1997) (Solomon, 2008). 
Given physician assumptions, patients presenting to the ED with VOC are at risk of being 
stigmatized as drug seekers by clinicians with inaccurate and offensive beliefs about this patient 
population, especially when the patient’s pain is inadequately treated and patients are 
requesting more medication for pain relief (Jenerette & Brewer, 2010) (Jacob, 2001). 
The second barrier is educating ED physicians and nursing staff on appropriate VOC 
pain management guidelines. In order for a VOC protocol to be implemented, the ED health 
care team must understand the underlying evidence on which the guidelines are built. According 
to a 2005 survey of physician from seven NIH funded universities with comprehensive sickle 
centers, many physicians treating patients in VOC are using unreliable measures of pain 
assessment for the purposes of guiding their treatment regime (Labbé, Herbert, & Haynes, 
2005). Specifically this survey found that clinicians commonly used physiological and behavioral 
measures to assess pain severity and infrequently used an objective pain rating scales to 
document pain intensity (Labbé, Herbert, & Haynes, 2005). The study found physicians to be 
relying on measures such as the patient’s facial grimace, heart rate, and blood pressure to 
assess the patient’s current pain status, all of which are unreliable (Labbé, Herbert, & Haynes, 
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2005). Patient vital signs are dependent on causes other than pain, such as hydration status, 
levels of stress, nutrition status, and infection. Facial grimace is not a reliable indicator for pain, 
either, since personality can create substantial variation in people’s expression of pain. As a 
consequence of inadequate knowledge of VOC management, clinicians are using incomplete or 
inaccurate indicators of pain to guide the treatment plan. Apart from the ethical questions 
associated with failing to treat patients who need it, delayed treatment may compound harm to 
the patient, and poor assessment is a major barrier to the implementation of a VOC protocol 
(Labbé, Herbert, & Haynes, 2005). 
In an effort to improve this unacceptable level of quality, many health systems are 
attempting to transform the ED’s SCD care practices. In addition to further educating ED staff, 
most are going about this reform by adopting VOC management protocols and/or implementing 
other unique quality improvement measures that incorporate the use of evidence base 
guidelines.  Despite the underlying reform measures, the goal of each effort is the same; to 
improve the use of evidence-based VOC management guidelines in addition to enhancing 
patient outcomes, management practices, and overall quality of VOC care in the ED. According 
to the literature some health reform initiatives are leading to VOC quality of care improvements, 
while others are not. Thus in order to discover the most effective approach to reform VOC 
quality of care, we need a systematic review of the question what are the best quality 
improvement practices (approach) regarding pain management of adults with sickle cell disease 
who present to the emergency department. 
Methods: 
In order to answer the question, “What are the best quality improvement practices 
(approach) regarding pain management of adult with sickle cell disease who present to the 
emergency department?” I searched the literature for English journal articles containing the 
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following keywords: sickle cell disease, pain management, and emergency services.  There 
were many articles that addressed sickle cell pain, priapism, acute chest, day hospitals, and 
drug trial in the ED. However I wanted to focus on articles that included adult sickle cell pain 
management in U.S.-based EDs that were focused on improving quality of care. Additionally, 
the articles had to include a quality improvement initiative with pre- and post- intervention 
patient outcomes which include variables such as patient satisfaction, hospitalization rate, 
length of stay, or timing to analgesia. This cross-sectional study design would allow for 
assessment of the quality improvement intervention, with respect to improving patient 
outcomes. The study had to be published within the past 15 years given the pace of updated 
guideline recommendations and to rule out studies that were practicing very outdated 
recommended treatment approaches.  
 
Inclusion and Exclusion Criteria 
 The inclusion criteria for this study were based on patient populations, type of care 
delivered, and setting of care delivery. The patient population was patient with sickle cell 
disease. Type of treatment delivered was pain management. The place or setting of care 
delivered was the emergency department. These inclusion criteria were chosen in such way to 
broaden the scope of literature results found using the database search. See Table 1 for a full 
overview of eligibility criteria. 
The exclusion criteria was based on age of the patient population, location of care 
delivery, present and type of quality improvement intervention, treatment types, and study 
design measures. Given that U.S. EDs can be structured, operated, and organized very 
differently than EDs in other countries, studies were excluded if they were not U.S.-based ED. 
Studies were excluded if they included children defined as patients younger than 18 years of 
age, given that this study’s research question is focus on adult patients with SCD. The study 
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was excluded if it lacked a quality improvement intervention, because this study seeks to find 
the best improvement interventions. Articles were excluded if the quality improvement 
intervention was not delivery of patient care-centered because this study is searching for best 
ED-based pain management practice to treat patients with SCD experiencing a VOC. Articles 
that were improving quality care solely through drug trials were excluded, because they are not 
holistically focusing on improving the care delivery approach to managing the VOC. Study that 
interventions that were not targeted to treating the vaso-occlusive crisis were excluded because 
our study is focusing on finding the best practices for pain management in the ED. Study 
designs that did not include a pre- and post-intervention patient outcome measures were 
excluded, because measurement patient outcomes as the result of care delivery are the best 
way to assess the interventions outcomes in comparison to the status quo.     
Search Strategy  
In order to find papers that addressed this study question, I searched Pubmed and 
Embase. I used the following MeSh terms and operators for the Pubmed Search:  
(anemia, sickle cell[mesh] OR sickle cell[title/abstract]) AND (Pain management[mesh] 
OR Analgesia[Mesh] OR pain[mesh] OR pain measurement[mesh] OR 
pain[title/abstract] OR painful[title/abstract] OR Analgesia[title/abstract] OR 
Analgesics[MeSH Terms] OR Analgesic*[title/abstract]) AND (Emergency service, 
hospital[mesh] OR emergency medicine[mesh] OR emergency[title/abstract] OR ED[title] 
OR ER[title]). After using the following search criteria: publication in the past 15 years 
and English only articles, the search recovered 213 articles on May 20, 2016.  
I used an adapted MeSh term search for the Embase query: 
(“sickle cell anemia”/exp OR “sickle cell”:ti,ab) AND (analgesia/exp OR pain/exp OR 
“pain measurement”/exp OR pain:ti,ab OR painful:ti,ab OR “analgesic agent”/exp OR 
analgesia:ti,ab OR analgesic*:ti,ab) AND (“emergency health service”/exp OR 
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“emergency medicine”/exp OR emergency:ti,ab OR ED:ti OR ER:ti). After using the 
additional search criteria: turned off mapping, publication within past 15 years, selected 
embase under sources, select English language, and selected articles, review, 
conference paper, article in press under publication type, my search recovered 223 
articles on May 20, 2016.  
Both searches resulted in a total of 436 recovered articles. Then duplicate articles were deleted 
and the two searches recovered a total of 285 unique articles. Titles and abstracts of all articles 
were reviewed for inclusion and exclusion criteria. Searching sickle cell disease and emergency 
medicine in clinicaltrials.gov recovered no relevant grey literature on May 20, 2016. 
 
Result analysis of the eligible studies  
 The eligible articles were reviewed to exclude articles that included children in the study 
population or that don’t characterize the study populations as being adult patients with SCD. 
Then the remainders of the eligible articles were reviewed to assess for the intervention and 
resulting patient-based outcome. Overall quality rating of the article were measured using a 
BAPAM framework which assessed the studies overall risk of bias, method analysis, degree of 
random error, generalizability of the results, and meaning of the results. There were 3 quality 
ratings, good, fair, and poor which were based on the BAPAM assessment. Good was defined 
as the study having no major weaknesses in the BAPAM assessment. Fair was having 1-2 
major weakness in the BAPAM assessment. Poor was having 3 or more major weakness in the 
BAPAM assessment.  
Results 
Search results 
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The Pubmed and Embase search recovered 5 articles that met eligibility criteria and 
discussed improving quality of emergency medicine care for patients with sickle cell disease. 
For full detail regarding the literature search used to recover the eligible studies see Figure 1. 
After assessing the full text of all five articles, 3 were found to lack age characteristics of the 
study population, therefore they were excluded because we could not rule in an adult sickle cell 
population. The age characteristic was important because in the US many health care 
institutions typically have an adult and children’s ED with different providers. Thus the 
systematic review will only include 3 studies. 
 
Description of eligible studies 
 The general description of the study and study characteristics is included in Table 2. The 
full evidence table is listed in appendix A Table 3 and Table 4.  
 
Synthesis of the evidence: 
 All studies were uniquely different from each other with respect to intervention, study 
size, and location of the intervention. The studies did however have the same goal in mind of 
improving the quality of SCD care through implementation of unique interventions that were 
used to improve compliance with guideline recommendation. The study by Givens, Rutherford, 
and Joshi, had the objective of reducing ED utilization, clinic visits, and hospital admission of 
patients with SCD via improving implementation of pain management guideline in concert with 
sickle cell (SC) clinic enhancing recruitment efforts of patient with SCD to the chronic 
management clinic. The study demonstrated that with this dual intervention the SCD population 
treated by these two healthcare systems required less ED visits, hospital admission, and 30 day 
readmission post-discharge. Additionally those patients who sought ED care for acute care were 
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more require likely to hospital admission. The quality of this study was rated overall as fair. 
(Givens, Rutherford, & Joshi, 2007) 
 The intervention by Neumayr, Pringle, and Giles implemented the use of a chart card 
microchip technology that contained encrypted patient information, treatment algorithms, and 
standard of care for treatment to improve patient satisfaction with ED care and provider 
accessibility to patient information and care protocols. The results of this intervention 
demonstrated that patient satisfaction with care remained unchanged according to survey 
results. However patient interviews of the chart card group found that timeliness, 
communication, staff knowledge, and attitudes had all improved, in addition to increased 
efficacy in health care, as a result of chart card use. The study quality rating was good overall. 
(Neumayr, et al., 2010) 
 The study by Tanabe, Hafner, and Martinovich implemented an analgesia protocol 
intervention that was slightly different across three different ED’s. Two of the sites allowed the 
nurse to administer subcutaneous opioids in the waiting room, while all three sites aimed to 
reassess and re-administer additional opioids using fifteen to twenty miniature intervals for the 
first three analgesia doses. All sites implemented nurse-initiated protocols that allowed the ED 
nurse the autonomy to administer the first analgesic dose prior to physician evaluation. The 
analgesia protocol’s major aim was to improve initiation timing of analgesia management and 
overall pain management practice and efficiency. Results from the study demonstrated that the 
intervention lead to improved difference in pain scores from ED arrival to discharge, however 
median timing to analgesia was longer and patient satisfaction did not improve in the post-
intervention period. Overall, the quality of this study was rated as good. (Tanabe P. , Hafner, 
Martinovich, & Artz, 2012) 
Discussion  
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With respect to the three eligible study interventions uncovered by this literature review 
none stood out as the best quality improvement reform practices with regard to pain 
management of adult patients with sickle cell disease who present to the emergency 
department.  All study interventions had their individual strengths, which left the evidence on this 
question as to the best quality improvement reform practice as mixed. The study by Givens et 
al, may have had the most influential results on patient outcomes by demonstrating significant 
reduction in ED visits, hospital admission, and 30-day readmission post-discharge. However the 
intervention’s overall quality was rated as fair because the study had two major weaknesses, 
the lack of numeral degree of improvement in the measured patient outcomes, and, the study 
population’s demographic and characteristic were not discussed.  The study by Tanabe et al, 
had the most polarizing results in which their analgesia protocol led to an improvement in pain 
score changes from ED arrival to discharge, however the intervention left patients waiting longer 
to receive initial analgesia administration and lead to no improvement in patient satisfaction 
ratings.  The chart card intervention by Lynne et al, had arguably the weakest effect on patient 
outcomes because patient satisfaction with care remained unchanged. Additionally the chart 
card intervention post- study intervention group interview showed that timeliness, 
communication, staff knowledge, attitudes and efficacy of healthcare had all improved. However 
the degree of improvement could not be quantified which was a shortcoming in study design. 
  
Secondary findings  
 The study by Givens et al, found that 87% of the patients who visited the hospital during 
the implementation year chose to return in the following post-intervention years. Thus the pre-
and post-intervention study population were significantly similar, given that this study is a 
retrospective cohort, the argument for causality has been further strengthened by this finding.  
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 With respect to the chart card study by Lynne et al, in those that responded to the pre-
study patient rated ED physician knowledge of SCD survey, only 39% of the adults rate their ED 
providers as excellent or very good. These proportions did not change in the post-study survey. 
Thus even though chart card contained knowledge of guidelines for standards of care patient 
did not report through survey that this was sufficient to improve ED providers knowledge of 
SCD. Additionally, only 5% of the 21 adult ED providers who completed a baseline survey 
regarding care of patients with SCD reported that familiarity with current NIH SCD management 
guidelines as excellent or very good. Only 52% of 21 adult ED clinician rated there familiarity 
with the current guidelines as good. These findings demonstrated that the close to 45% of ED 
clinicians had a knowledge deficit with respect the SCD condition and were lacking a good 
knowledge of the most updated guidelines for SCD management.  The study also uncovered 
that access to pain and fever protocols was excellent or very good for only 35% of the 21 adult 
ED clinicians. This finding demonstrated the need for improved access to treatment protocols, 
which was a problem that chart card was attempting to address. 
 The analgesia protocol by Tanabe et al had many secondary findings the first being 
between pre- and post-implementation period there was a significant rise in the use of oral and 
subcutaneous route access and reduction in IV route usage for analgesia administration. This 
may have been secondary to common finding that most patients with SCD have poor IV access. 
With respect to medication usage there was a reduction in morphine sulfate use and rise in 
dilaudid use. This difference could be inconsequential because they can both achieve the same 
pain relieving effects but it requires more morphine to achieve dilaudid’s pain relieving effects.  
 
Limitations of the review 
The literature review had certain limitations that were mainly search related. The search 
was very limited by exclusion of children as study participants especially in cases where the 
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study design did not separate the adult and children study groups respectively and separately 
analyze the results. As mentioned earlier, pediatrics studies were excluded from eligible studies 
because pediatric ED and adult ED are significantly different with respect patient population 
served and diversity of problems, thus they face different types of limitations.  Search results 
were also limited because studies that were non-U.S. based were excluded, because ED 
variations between countries are vastly different depending on resource availability, 
organization, and practicing policies. Thus inclusion of foreign studies would limit the 
generalizability of study results.  
 
Limitation of the evidence 
The main limitation of this systematic review evidences is the inappropriate combining of 
heterogeneous studies. All of the eligible studies have different interventions, outcomes 
measures, and regionally different study populations. These differences limit our ability to assert 
which quality reform interventions yield the best pain management practices for adult patients 
with sickle cell disease who present to the emergency department. Specifically, heterogeneity in 
the study prevents effective comparison of different study interventions because there are 
different outcomes measures and source population. The heterogeneity is a major limitation of 
this study because the systematic review yielded only a few eligible articles, which limits our 
ability to compare contrasting studies. 
Conclusion  
 This literature review demonstrated mixed results with respect to the finding the best 
quality improvement reform practices with regards to pain management of adult patients with 
sickle cell disease who present to the emergency department. Of the three eligible studies the 
Givens et al ED pain management protocol with concurrent hematology recruitment intervention 
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may have shown the most benefits with respect to improving multiple patient outcomes such as 
ED visits, hospital admission, and post-discharge readmission rates. However given that quality 
of this study was fair at best, additional research is required to explore the potential implications 
for such interventions given a stronger study design.  
 
 
 
Figure 1. QUORUM Flow diagram outlining the search process for eligible studies included in 
the systematic review 
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Table 1. Study Eligibility Criteria 
 
 
 
  
PICOTS  
Criteria 
   
Population(s)  
Adult patient with sickle cell disease in the US 
  
Interventions  
Emergency department-based  quality improvement programs targeted at improving care 
delivery for patient with sickle cell disease  
  
Comparators  
Patient outcome measures pre and post quality improvement intervention   
Outcomes 
Patient satisfaction with pain management, admission rate, 30 re-admission rates, and/or 
timing to analgesia 
Timing 
Outcome assessment must be measure for at least 1 year prior to intervention 
implementation and 1 year post study-implementation, if the study design is a retrospective 
cohort. If the study is a randomized control design outcome assessment must be measure 
for at least 1 year. 
Settings 
Emergency Department programs 
Study Designs  Cross-sectional survey 
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First 3 Authors, year of 
publication, title, and 
citation 
Sample size and study 
objective  
Study setting, study 
duration, and  
Study design 
Sample 
characteristics  
Baseline demographic characteristic  
Givens, Rutherford, and 
Joshi,  2007, 
Impact of an emergency 
department pain 
management protocol on 
the pattern of visits by 
patients with sickle cell 
disease (Givens, 
Rutherford, & Joshi, 2007) 
 
223 adult patient 
Study Objective: 
To measure how 
implementation of pain 
management guidelines in 
concert with clinic case 
management influences 
emergency department 
(ED) utilization, clinic 
visits, and hospital 
admissions for patients 
with sickle cell disease 
 
Study Setting: Emergency 
Department and 
Hematology clinic at UT 
Southwestern and Parkland 
Memorial Hospital 
 
Study Duration: 
4 years; year 1 = pre-
intervention, years 2-4 = 
post-intervention. Study 
period = 2000-2004.  
 
Study Design: 
Retrospective cohort 
Adult patient 
with 
diagnoses of 
sickle cell 
disease 
visiting the ED 
for care  
Age: N/A 
Gender: N/A 
SCD-SS: N/A 
SCD-SC: N/A 
SCD-Sß
0
 thalassemia: N/A 
SCD-Sß
+
 thalassemia: N/A 
Neumayr, Pringle, and 
Giles, 2010, 
Chart Card: Feasibility of a 
tool for improving 
emergency department 
care in sickle cell disease 
(Neumayr, et al., 2010). 
44 adult patient  
 
*data only for adult 
patients 
 
Study Objectives: 
To determine the effect 
that Chart Card has on 
patient satisfaction, 
provider accessibility to 
patient information and 
care protocols in the ED. 
Study Setting:  
Adult and pediatric 
Emergency Department in 
San Francisco Bay area of 
California: Children’s 
Hospital & Research Center 
Oakland and a nearby 
community hospital   
 
Study Duration: 
1 year duration: February 
2007 to March 2008 
 
Study Design: 
Randomized-control study 
52% experimental (card) 
48% control group (no-card) 
 
Main outcome: patient 
satisfaction with care rated 
as (excellent, very good, 
good, fair, poor). This was 
measure at pre- and post- 
study for both experimental 
and control group.   
Adults and 
children who 
are patients 
with a 
diagnoses of 
sickle cell 
disease 
visiting the ED 
for care 
Combined: (N=44) 
Age: 31.8 (SD: 13.0) 
Gender: 28 (64 %) Female 
SCD-SS: 27 (64%) 
SCD-SC: 13(30%) 
SCD-Sß
0
 thalassemia: 1 (2%) 
SCD-Sß
+
 thalassemia: 3 (7%) 
Experimental: (N=23)  
Age: 32.6 (SD: 13.1) 
Gender: 12 (52 %) Female 
SCD-SS: 16 (70%) 
SCD-SC: 5 (22%) 
SCD-Sß
0
 thalassemia: 1 (4%) 
SCD-Sß
+
 thalassemia: 1 (4%) 
Control (N=21): 
Age: 31 (SD: 13.2) 
Gender: 16 (76 %) Female 
SCD-SS: 11 (52%) 
SCD-SC:  8 (38%) 
SCD-Sß
0
 thalassemia: 0 (0%) 
SCD-Sß
+
 thalassemia: 2 (10%) 
 
*data only for adult patients 
Tanabe, Hafner, and 
Martinovich., 
2012, 
Adult emergency 
department patients with 
sickle cell pain crisis: 
results from a quality 
improvement learning 
collaborative model to 
improve analgesic 
management (Tanabe P. , 
Hafner, Martinovich, & 
Artz, 2012). 
342 adult patients 
 
 
Study Objective: 
1-To measure differences 
in pain management 
practices and patient 
reported outcomes, pre- 
and post- ED analgesic 
protocols implementation 
for adults with SCD. 
2-To assess the effects of 
site and visit frequency on 
differences in pain score 
and timing to analgesic. 
Study Setting:  
3 academic Adult 
Emergency Department in 
Illinois 
 
Study Duration: 
Pre-implementation period 
= 10 months (site 1 & 2) 
and =3 months (site 3). 
Post –implementation 2 
years. October 2007 to 
September 2009. 
 
 
Study Design: 
Prospective cohort  
 
Adult (18 
years and 
older) patient 
with 
diagnoses of 
sickle cell 
disease 
visiting the ED 
for care who 
speak English 
Site 1 (N=99) 
Age: 35 years (SD: 11) 
Gender: 52 (51%) female 
African American or Black: 97 (99%) 
 
Site 2  (N=31) 
Age: 31 years (SD: 10) 
Gender: 18 (58%) female 
African American or Black: 31 
(100%) 
 
Site 3 (N=212) 
Age: 31 years (SD: 10) 
Gender: 129 (61%) female 
African American or Black: 206 
(98.6%) 
Table 2. Literature Review Study Characteristics 
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First 3 Authors, year 
of publication, title, 
and citation 
Intervention   Health outcome  Harms  Other   
Givens, Rutherford, 
and Joshi,  2007, 
Impact of an 
emergency 
department pain 
management protocol 
on the pattern of visits 
by patients with sickle 
cell disease (Givens, 
Rutherford, & Joshi, 
2007) 
 
Intervention:  
guideline-based (on 2000-
2001 SCD guidelines) ED 
pain management for 
patient with SCD:  
1) Implemented the use of a 
sickle cell pain management 
algorithm (provided 
treatment protocol from 
initial ED assessment to 
inpatient admission or ED 
discharge.) 
2) Provided triage nurse 
with standing orders that 
allowed nurses to initiate 
pain management with oral 
medication for patient with 
SCD presenting with VOC. 
3) Prioritized rapid treatment 
and pain control with 
parental morphine or 
hydromorphone. 
4) Provided discharged 
patients with outpatient oral 
medication (limited to 
hydrocodone preparations 
when filled at the ED’s 
discharge pharmacy) for 3 
days post-ED visit with 
referral for follow-up in 
Hematology clinic. 
 
 
*This intervention was 
concurrent with their 
hematology clinic initiating a 
proactive recruitment of 
sickle cell patients for care 
with the introduction of a 
formal case management 
program for patients with 
SCD. Additionally patient 
gained increased access to 
their outpatient hematology 
clinic with initiation of this 
intervention as well. 
Patient Outcomes: 
 
Total Hospital visits (SCD clinic + 
ED visits) per year :  
remain stable over all four study 
years (p>0.10 Wilcoxon rank sum 
test) 
 
SCD hospital admissions:  
Declined** over the 4 year study 
period (p=0.001, group trend 
analysis) 
 
ED visit that result in admission: 
Increased from 29% in year 1 to 
43% in year 4 (p=0.04, fisher 
exact test) 
 
ED visit relative to SCD clinic 
visits:  
Declined** significantly over the 
four year study periods (p= 
0.001; group trend analysis)  
 
Likelihood of ED return within 30 
days of ED discharge: 
Declined** significantly over the 
four year study period (p = 0.001, 
group trend analysis) 
 
 
*both hematology recruitment 
efforts and ED intervention 
probably lead to improved patient 
outcomes over the four year 
study period. 
**studies did not provide 
numerical data on extent of 
increase and decline for the 
following patient outcomes  
 
The study 
had no 
reports of 
harm to 
study 
participants.  
-87% of the patient 
that visited the 
hospital during the 
implementation year 
chose to return the 
following post-
intervention years. 
Neumayr, Pringle, and 
Giles, 2010, 
Chart Card: Feasibility 
of a tool for improving 
emergency 
department care in 
sickle cell disease 
(Neumayr, et al., 
2010). 
Intervention:  
Chart card: is a card with 
microchip technology that 
contains encrypted patient 
information, treatment 
algorithms, and standard of 
cared guidelines for 
management of pain, fever, 
and acute chest syndrome. 
Chart cards can only be 
read with specialized card 
readers and only patient 
personal information 
number and photographic 
identification to positively ID 
the patient and allow access 
to the database on the chart 
Patient Outcomes: 
Patient satisfaction: 
 
In the adult group of those that 
respond to the pre-study patient 
satisfaction survey only 33% 
rated their care as excellent or 
very good.  
 
Of those who complete both pre-
study and post-study survey the 
percentage of those who rated 
their care as excellent or very 
good increased from 47% to 66% 
(McNemar test, p=0.05) from pre- 
to post-study period. No 
The study 
had no 
reports of 
harm to 
study 
participants. 
In the adult group 
those that respond to 
the pre-study patient 
rated ED physician 
knowledge of SCD 
survey, only 39% of 
adults rate their ED 
providers as 
excellent or very 
good. These 
proportions did not 
change in the post-
study survey.   
 
Of the 21 adult ED 
providers who 
completed a baseline 
 39 
 
card. The card offer solution 
for sharing medical records 
across different EMR.  
differences between pre- and 
post- study groups were found. 
 
At studies end, 14 of 23 adult in 
the chart card (experimental) 
group were interviewed about 
their experiences. The response 
found that timeliness, 
communication, staff knowledge, 
and attitudes had all improved, in 
addition to increased efficacy in 
health care. 
 
*Patients in the card group did 
forget to take Chart cards to the 
ED on several occasions and ED 
staff forgot to ask for the cards on 
some occasions as well. 
 
 
survey regarding 
care of patients with 
SCD, only 5 % rated 
their familiarity with 
current NIH 
management 
protocols for SCD as 
excellent or very 
good. Only 52% 
rated it as good. Only 
35% of adult 
physicians rated 
there access to pain 
and fever protocols 
as excellent or very 
good.   
 
Tanabe, Hafner, and 
Martinovich., 
2012, 
Adult emergency 
department patients 
with sickle cell pain 
crisis: results from a 
quality improvement 
learning collaborative 
model to improve 
analgesic 
management (Tanabe 
P. , Hafner, 
Martinovich, & Artz, 
2012). 
Intervention: 
Implementation of an 
slightly analgesia protocols 
across all 3 study sites: 
-two of the sites allowed 
nurses to administer 
subcutaneous (SC) opioids 
in the waiting room. This 
was only in circumstances 
were beds were not 
immediately available.  
-all three analgesic 
protocols used morphine 
sulfate or hydromorphone 
(preferred route IV>SC>IM) 
for pain management. 
-all sites reassessed and re-
administered additional 
opioids using 15 to 20 
minute intervals for the first 
3 does.  
-ED nurses were granted 
the autonomy to administer 
the first analgesic dose prior 
to physician evaluation, this 
measure applied to all sites. 
Patient Outcomes: 
 
Time to analgesic administration: 
-the mean time to analgesic 
administration was shorter during 
the pre-implementation period 
than post-implementation period 
(114 mins vs. 131 mins, 
t(2871)=3.40,  p=0.001).  
 
Change in pain scores from 
arrival to discharge  
-the mean difference in arrival to 
discharge pain scores was larger 
in the post-implementation period 
than pre-implementation period (-
4.1 vs. -3.6, t=2.6, p =< 0.01).  
 
Patient report outcomes: 
No statistically significant 
differences in patient reported 
satisfaction scores were found 
between pre and post 
implementation study periods. 
The pre-implementation vs. post-
implementation satisfaction score 
(10-worse, 1- best) was 3.4 (SD: 
2.9) vs. 3.2 (SD: 2.4) which 
indicated that patient maintained 
moderate satisfaction with ED 
management of pain throughout 
the study period. 
 
The study 
had no 
reports of 
harm to 
study 
participants. 
Analgesic agents 
and route: 
Between pre- and 
post- implementation 
study period there 
was a significant rise 
in oral and 
subcutaneous 
routes, and reduction 
in IV routes. 
Additionally there 
was a reduction in 
morphine sulfate use 
and rise in 
hydromorphone use. 
 
Nurse administration 
of analgesia 
(anecdotally): 
-for the two sites that 
allowed triage nurses 
to administer 
analgesia; these 
triage nurses 
reported many 
barrier to providing 
opioids in the waiting 
room including: 
-difficulty leaving a 
busy triage area to 
travel to main ED 
treatment area to 
obtain opioid 
administration area. 
-triage nurse 
expressed reluctance 
on their ability to 
monitor patient in the 
in the waiting room 
after administering 
opioids. 
-Many ED nurse 
report reluctance to 
administer opioids 
despite the standing 
orders prior to 
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physician evaluation.  
Table 3. Literature Review Study Results. When including the site and study period as crossed 
factors predicting time to analgesia with ANOVA modeling found that only individual site effects 
were significant. For sites 1, 2, and 3 pre and post median difference were 5 (95% CI: -3 to 12), 
6 (95% CI: 1 to 12), and -5 (-20 to10) respectively. Thus all among all site there was a slight 
increase in time to administration of initial analgesia from pre- to post-implementation period 
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First 3 Authors, year 
of publication, title, 
and citation 
Overall risk of bias Analysis Precision and 
degree of 
random error 
Generalizability Meaning Overall quality 
rating (good, 
fair, poor) 
Givens, Rutherford, 
and Joshi,  2007, 
Impact of an 
emergency 
department pain 
management protocol 
on the pattern of visits 
by patients with sickle 
cell disease (Givens, 
Rutherford, & Joshi, 
2007) 
 
Selection bias- the 
potential for 
selection bias is 
low given that a 
retrospective EMR 
assessment for all 
sickle cell patient 
visits to the ED and 
inpatient 
department were 
collected for all 
patients with a 
primary or 
secondary 
diagnosis of a 
sickle cell pain 
crisis for the entire 
duration of the 
study period, to 
rule in study 
participants. 
 
Measurement bias- 
the potential for 
measurement bias 
is low because 
each 
hospitalization and 
ED visit by each 
patient was 
assessed for 
number of visits to 
the hematology 
clinic by that 
patient during the 
same time frame 
(post-discharge 
period) using EMR 
documentation of 
the visit occurring.  
 
Given that 87% of 
patient who visited 
these health care 
systems during the 
implementation 
period year 
decided to return, 
the group 
adherence to the 
intervention was 
moderately good 
throughout the 
study period. 
Overall analysis of 
the data was 
appropriately 
executed. A fisher 
exact test was 
used to compare 
dichotomous 
groups and a 
Wilcoxon rank 
sum test was 
appropriately 
used to calculate 
p-values for two 
groups of 
continuous data 
that were being 
compared. Group 
test for trend 
(STATA 
intercooled 8.9 
“nptrend”) was 
used to 
appropriately 
analyze 
categorical date 
across all 4 study 
years. 
According to the 
study results, p 
valves for the 
group trend 
analysis were all 
statistically 
significant p-
value of less 
than 0.05. 
However no 
numerical 
magnitudes were 
reported for the 
trends that were 
noted over the 
study period, 
which really calls 
into question the 
magnitude of 
affect that the 
study 
intervention had 
on this 
population of 
patient with 
sickle cell 
disease.   
The results are 
generalizable to 
the SCD patient 
population 
using University 
of Texas 
Southwestern 
Medical Center 
and Parkland 
Memorial 
Hospital. But, 
given that the 
study 
population 
included adult 
patients with 
SCD with 
undefined 
characteristic 
and 
demographic. I 
could not 
potentially 
generalize the 
result of this 
intervention to 
U.S. ED 
teaching 
hospital with 
Sickle cell 
hematology 
clinics because 
the study 
doesn’t 
adequately 
define the 
characteristics 
of it study 
population 
except that the 
patients have 
SCD and are 
adults.   
The study 
demonstrated 
that with 
implementation 
of the study 
intervention the 
SCD population 
treated by 
these two 
healthcare 
systems 
required less 
visits to the ED, 
hospital 
admissions, 
and 30 day 
readmissions 
post-discharge. 
Additionally 
those who did 
have an ED 
visit in the post-
intervention 
period were 
more likely to 
require 
inpatient 
admission, 
which may 
point to the fact 
that those 
seeking ED 
hospital care 
were potentially 
sicker patients 
requiring 
relatively more 
health care 
services.  
Fair 
-minimal bias  
-good statistical 
analysis tests 
-study lack the 
numeral degree 
of improvement 
in measured 
patient 
outcomes.  
- The study 
population’s 
demographic 
and 
characteristic 
were not 
discussed.  
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Neumayr, Pringle, and 
Giles, 2010, 
Chart Card: Feasibility 
of a tool for improving 
emergency 
department care in 
sickle cell disease 
(Neumayr, et al., 
2010). 
Selection bias- 
there was low 
potential for 
selection bias 
given that all 
patients with any 
confirmed SCD 
diagnosis were 
eligible and only 
those excluded 
from the study 
didn’t visit the ED 
within the past year 
prior to enrollment. 
Study participants 
were effectively 
randomized to 
either study group 
and there were no 
significant 
demographic 
differences 
between study 
groups. 
 
Measurement bias- 
the potential for 
measurement bias 
is low given that 
measurements 
were performed 
identically across 
intervention and 
control study 
groups.  
Overall analysis of 
the data was 
correctly 
executed. The 
study population 
characteristics 
such as baseline 
measure and 
demographic 
were compared 
between study 
groups 
appropriately 
using a chi-
squared test (with 
yates continuity 
correction, when 
indicated) for 
categorical data. 
Additionally a 
student t-test was 
appropriately 
used for 
continuous 
variables.  
McNemar test of 
correlated 
proportions 
appropriately 
used as well to 
compare patient 
rating surveys 
pre-study entry to 
post-study entry.    
According to 
study results, p-
valve for 
McNemar test 
was insignificant 
given a value of 
0.05. Thus the 
difference 
between pre and 
post- study 
survey results 
with respect to 
the percentage 
of participants 
who rated their 
care as very 
good or 
excellence was 
not statistically 
or significantly 
different. 
The results of 
the study 
intervention are 
generalizable to 
adults and 
children’s with 
SCD who utilize 
the adult and 
pediatric ED in 
San Francisco 
Bay area of 
California at 
least annually. 
The result 
would be 
difficult to 
generalize to all 
other US ED 
given that the 
medical team’s 
knowledge, 
prospective, 
and attitudes 
towards 
treating their 
SCD population 
may vary 
significantly.   
The study 
demonstrated 
that with 
implementation 
of the study 
intervention the 
SCD population 
getting the 
chart care 
intervention 
reported that 
timeliness, 
communication, 
staff 
knowledge, 
efficacy of care, 
and attitudes 
had all 
improved, even 
though patient 
satisfaction with 
care remain 
statistically 
unchanged.    
Good 
-minimal bias  
-good statistical 
analysis tests 
-good 
characterization 
of study 
population 
demographic 
and disease 
type 
Tanabe, Hafner, and 
Martinovich., 
2012, 
Adult emergency 
department patients 
with sickle cell pain 
crisis: results from a 
quality improvement 
learning collaborative 
model to improve 
analgesic 
management (Tanabe 
P. , Hafner, 
Martinovich, & Artz, 
2012). 
Selection bias-the 
potential for this 
bias was low-
moderate, given 
that all adult (18y/o 
or older) ED visits 
with a chief 
complaint of VOC 
who were seen by 
one of the three 
EDs during the 
study period were 
included in the 
medical record 
review data portion 
of the study. These 
patients were also 
eligible for a 
participation in a 
follow-up interview 
as well, if they 
spoke English and 
were able to 
provide follow-up 
contact 
information. There 
was potential for 
selection bias in 
choosing the 10 
participant every 3 
months who be 
invited to be 
Overall analysis of 
the data was 
properly 
executed. 
Ordinary least 
squares 
regression 
modeling with 
ANOVA was used 
to predict pain 
change (during 
ED course) and 
time to analgesia 
using variables: 
visit (3 groups 
depicting patient 
utilization history 
of the ED), period 
(pre or post 
implementation 
study period), and 
site (3 ED sites) 
and interaction 
term were 
assessed 
between different 
variables to create 
more  accurate 
predictive models. 
Additionally 
median time to 
analgesia and 
Most of the 
confidence 
intervals used to 
assess median 
difference in 
analgesia time 
between pre- 
and post- 
implementation 
of analgesic 
protocol were 
wide around the 
point estimate. 
Approximately 3 
of 8 median 
difference were 
found to be 
insignificant 
(95% CI crossed 
0, thus overall 
the study results 
for this measure 
were not very 
precise or 
statistically 
significant. 
 
Most of the 
confidence 
intervals used to 
assess median 
difference in 
The results of 
this studies 
intervention are 
generalizable to 
academic adult 
ED in Illinois, 
treating SCD 
population with 
similar 
characterized 
demographic. 
However the 
result would be 
difficult to 
generalize to all 
other US ED 
given that the 
medical team’s 
knowledge, 
prospective, 
and attitudes 
towards 
treating their 
SCD population 
may vary 
significantly.    
The study 
demonstrated 
that 
implementation 
of this 
intervention 
lead to 
improved 
difference in 
pain score from 
ED arrival to 
discharge, 
however this 
intervention 
didn’t 
significantly 
improve timing 
to analgesia or 
patient 
satisfaction with 
ED pain 
management. 
Good 
-minimal bias  
-very good 
statistical 
analysis tests 
-good 
characterization 
of study 
population 
demographic 
and disease 
type 
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interviewed, 
because this 
process was not 
discussed or 
further explained. 
 
Measurement bias- 
the potential for 
measurement bias 
is low given that 
measurements 
were performed 
identically 
throughout the 
duration of the 
study period. 
median change in 
pain score were 
appropriately 
evaluated 
between pre and 
post- 
implementation 
period using an 
independent 
Hodges-Lehman 
95% CI with 
independently 
sampled median 
and with 
associated 
nonparametric 
inferential tests. 
Chi-square test 
for independence 
was used 
correctly to 
evaluate changes 
in percentage of 
analgesia uses 
between pre- and 
post- 
implementation 
study periods. 
Independent 
samples t- were 
also appropriately 
used to compare 
patient 
satisfaction score 
between pre- and 
post-
implementation 
study periods. 
ANOVA analysis 
using pairwise 
comparisons of 
the three 
individual ED sites 
to evaluate for 
any significant 
difference in 
number of ED 
visits per 
individual 
patients, was an 
appropriately 
statistical test to 
use.  
change in pain 
scores during 
ED visit between 
pre- and post- 
implementation 
of analgesic 
protocol were 
moderately 
narrow around 
the point 
estimate, 
however 
Approximately 2 
of 8 median 
difference were 
found to be 
insignificant 
(95% CI crossed 
0, thus overall 
the study results 
for this measure 
were moderately 
precise and 
statistically 
significant. 
Table 4. Literature Review Evidence Table 
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Appendix 2: Consent and Structured Interview Protocol for ED Leaders 
 
Consent Information: 
Hello, my name is Jackie Queen. Thank you so much for talking with me today.  I am a 
4th year medical student at The University of North Carolina at Chapel Hill taking a year away 
from medical school to work on my master’s degree in public health.  I am doing this research 
for my master's paper in the Health Care & Prevention MD-MPH degree program.   
 
I have asked to interview you because of your vast understanding of the operation of the 
UNC Health Care System’s emergency departments.  I am interested in your views on how we 
could improve quality of care for patient with SCD in the emergency department.  
 
My faculty adviser is Dr. Sue Tolleson-Rinehart.  She is a faculty member in the UNC 
Schools of Medicine and Public Health.   
 
The interview has several open-ended questions. The interview should last 15 to 30 
minutes, or however long you can give me depending on your time and what you want to tell 
me.   
 
I would like to record this interview on a digital voice recorder to make absolutely sure 
that I have the most accurate record of your comments.  I will not record this interview without 
your permission. If you do grant permission for this conversation to be recorded on a digital 
recorded, you have the right to revoke recording permission and/or end the interview at any 
time. I will transcribe the interview, and I will give you a copy of the transcript at your request.  
As you will see, I am asking for permission to quote you by name and position, because this 
gives my research more credibility.  If you would rather remain anonymous, I will refer to you as 
“an emergency medicine leader” and your responses will not be shared with superiors. 
 
 
I will keep the digital interview files encoded on my computer and on my advisor's 
computer.  We will delete the files after I have made transcripts of them.  The digital files and my 
transcripts of them will be protected by passwords. Dr Tolleson-Rinehart and I will be the only 
people who have the passwords.  
 
If you have any questions about the research now, please ask. If you have questions 
later about the research, you may contact me by phone at (908) 420-2072 or by e-mail at 
Jackie_Queen@med.unc.edu. 
      
Dr. Tolleson-Rinehart and I intend to try to publish the results of this project, and will be 
glad to make findings available to you.   If you want to ask Dr. Tolleson-Rinehart any questions, 
please send a message to suetr@unc.edu or call 919.843.9477.   
 
This study will not be of any direct benefit to you the participant. 
 
All research on human volunteers is reviewed by a committee that works to protect your 
rights and welfare.  If you have questions or concerns about your rights as a research subject, 
or if you would like to obtain information or offer input, you may contact the Institutional Review 
Board at 919-966-3113 or by email to IRB_subjects@unc.edu. 
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Do you have any additional questions at this time? 
 
Before we continue, would you please agree to any or all of the statements I’m about to 
read?   
 
 
 
   I AGREE to having this interview tape recorded with a digital voice recorder.   
 
 
 
   I  GIVE PERMISSION for the following information to be included in publications 
resulting from this study: 
 
 
  my name    my title      direct quotes from this interview  
 
 
 
 
 
 
Name of Participant (please print)   Date 
 
 
Thank you for your help with my project!  Now we are ready to begin.    
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Semi-Structured Interview Question  
As you know, when I asked to interview you, I mentioned that I wanted to discuss how the UNC 
ED can best meet the goals of the NHLBI guidelines for managing patients’ Sickle Cell Disease.  
As I ask questions, I will mostly be thinking about these guideline recommendations for patients 
who present with Vaso-occlusive pain crisis: 
 
 Rapid initiation of analgesia within 30minutes of triage or 60 minutes of registration; 
 Assessing patients every 15 to 30 minutes and re-administering opioids until the 
patient’s pain is under control, and continuing to assess that pain remains under control; 
and 
 Using the pain management protocol developed by the patient’s SCD provider whenever 
possible. 
 
1.  Now, with those guidelines in mind, here at UNC, how often do ED providers and trainees 
discuss ED management of patient with SCD?  Are there any special training or preparation 
seminars requirements?   
 
2.  And how often does the ED as a whole think about improving SCD management as a quality 
of care problem?   
 
3.  Do you think the NHLBI guidelines for SCD are easily available to doctors, nurses, and 
trainees? 
 3.a.  (If no):   What would make them easier to get and use? 
3.b. (If yes or no):  Are the guidelines enough, or do we need something more?  
What?  
 3.c.  (If yes or no):  How could Epic help make the guidelines more useful? 
 
4.   From your vantage point, what are some of the things that work really well in the ED’s 
management of SCD patients? 
 
 4.a.   And how could those things be improved even more? 
 
5.  And what do you see as the greatest barriers to improving Sickle Cell care?   
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 5.b. What would best help you remove those barriers? 
 
 5.c. Given these barriers, how well prepared do you think the ED is to care for 
patients with SCD? 
 
6.  I’m particularly interested in your views on improving two elements of quality of SCD care:  
the use of individualized pain management plans, and better referral communications. 
 
 6.a.   First, what would it take to make individualized pain management plans the 
standard of care in the ED? 
 
 6.b.  And if you could change things, how would you improve communications and 
referral management between the SCD specialist and the ED provider? 
 
7. I’m almost done!  As I know you know, the literature suggests many providers are 
uncomfortable with caring for SCD patients, while others are quite comfortable.  How would you 
judge the comfort of the providers in the UNC ED?  By “providers” I mean doctors, nurses, and 
trainees. 
 
And what might make them (even) more comfortable? 
 
8. Last question!  Is there anything else you want to tell me about the ED’s care of patient 
with SCD who present here? 
 
Thank you again!  We’ll be happy to send you a copy of my master’s paper if you would like. 
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Appendix 3: List of ED leader Stakeholder  
 
Name   Title/Position 
1. Heather Tuttle  RN, BSN, BS, CEN 
UNC Trauma Outreach Coordinator/Trauma Nurse Educator 
Mid Carolina RAC Coordinator 
 
2.  Leah Hatfield  PharmD 
Emergency medicine clinical specialty 
Assistant Professor of Clinical Education - UNC Eshelman 
School of Pharmacy 
 
3. ED leader 1 MD, 
UNC Department of Emergency Medicine 
 
4. Jeff Phillips RN, MSN, CEN  
Interim Nurse Manager 
UNC Emergency Department at UNC Hospitals 
 
5.  Christian Lawson MD, Director, UNC Emergency Medical Services 
UNC Emergency Medical Services 
 
6. ED leader 2 MD, FACEP 
Department of Emergency Medicine 
 
7. Kevin Biese MD, MAT 
Associate Professor, UNC Department of Emergency Medicine  
Vice-Chair of Academic Affairs  
Clinical Associate of Professor of Internal Medicine, Division 
Geriatrics; Co-Director, Division of Geriatric Emergency 
Medicine 
 
